pretickt

When does Pfizer report earnings?

Pfizer Inc. · end-of-day data as of Nov 13, 2026

Pfizer
PFE · $165B
$28.89+0.2%
Nov 13, 2026 · close
$28$30SepOctNov9:3016:003 months +7.6%Nov 13 · close
▲ 4
  • FCF yield+7.2%
  • Trendbullish
  • MAs3 of 4
  • Sector▲ +15.9%
Neutral
  • Earnings in81d
  • P/E41.5x
  • RSI48
  • Support-2.4%
  • Resistance+4.4%
  • Off 52w high-8.1%
  • Volume0.6x
  • Bollingerlower half
  • News
  • ConsensusHold · 28
  • PT$29.43 +1.9%
  • 52w range$24–$31
  • ATR+2.4%
  • Off ATH-53.2%
  • InsidersNone in 90d
▼ 3
  • P/E vs own+47.8%
  • P/E vs sector+28.7%
  • MACD-0.16

Updates with the 15-min delayed price. Not a forecast or investment advice.

Pfizer PFE reports its next earnings on Tuesday, Feb 2, 2027, before the open, an estimated date the company has not confirmed yet. Analysts expect EPS of $0.69 on revenue of $17.22B. Pfizer beat the EPS estimate in 8 of its last 8 reports, and the stock moved ±2.4% on average the session after. The last report, on Nov 3, 2026: EPS of $0.87 against $0.73 expected and revenue of $16.58B against $15.85B; the stock fell 2.2% the next session.

The stock around its reports

⇔⇕$19.91$23.15$26.38$29.62Nov 24Apr 25Sep 25Feb 26Jul 26Dec 26DEAEDDEEDDEAEDAADEEDE

Last close $28.89 · +26.0% over 2y · E earnings · D dividend · S split · A analyst rating change

Quarterly results

Q3 FY2026: Revenue -0.4% year over year, free cash flow 29.0% of revenue, operating margin 22.1%.

RevenueFree cash flow
Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Q3 FY2026Sep 27, 2026$16.58B0.56$4.8B75.7%22.1%19.6%
Q2 FY2026Jun 28, 2026$15.03B-0.04$302M72.8%23.5%-1.6%
Q1 FY2026Mar 29, 2026$14.45B0.47$2.18B75.4%29.5%18.6%
Q4 FY2025Dec 31, 2025$17.56B-0.29$4.5B70.0%21.0%-9.4%
Q3 FY2025Sep 28, 2025$16.65B0.62$4B74.9%33.2%21.3%
Q2 FY2025Jun 29, 2025$14.65B0.51-$1.2B74.2%25.7%19.9%
Q1 FY2025Mar 30, 2025$13.71B0.52$1.77B79.3%32.3%21.6%
Q4 FY2024Dec 31, 2024$17.76B0.07$5.8B66.7%17.9%2.3%